NDC 0121-0677

TRICITRATES

Potassium Citrate, Sodium Citrate, And Citric Acid Monohydrate

TRICITRATES is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Pharmaceutical Associates, Inc.. The primary component is Potassium Citrate; Sodium Citrate; Citric Acid Monohydrate.

Product ID0121-0677_7538d302-77c9-b5ad-e053-2991aa0a81c4
NDC0121-0677
Product TypeHuman Prescription Drug
Proprietary NameTRICITRATES
Generic NamePotassium Citrate, Sodium Citrate, And Citric Acid Monohydrate
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2005-05-25
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NamePharmaceutical Associates, Inc.
Substance NamePOTASSIUM CITRATE; SODIUM CITRATE; CITRIC ACID MONOHYDRATE
Active Ingredient Strength550 mg/5mL; mg/5mL; mg/5mL
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0121-0677-16

473 mL in 1 BOTTLE (0121-0677-16)
Marketing Start Date2005-05-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0121-0677-16 [00121067716]

TRICITRATES SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-05-25

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM CITRATE550 mg/5mL

OpenFDA Data

SPL SET ID:2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309317
  • Pharmacological Class

    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]
    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]
    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]
    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]
    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]
    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]

    NDC Crossover Matching brand name "TRICITRATES" or generic name "Potassium Citrate, Sodium Citrate, And Citric Acid Monohydrate"

    NDCBrand NameGeneric Name
    0121-0677TRICITRATESPOTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE
    17856-0677TRICITRATESPOTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE
    62135-438TricitratesTricitrates
    69367-322Potassium Citrate, Sodium Citrate, and Citric AcidPotassium Citrate, Sodium Citrate, and Citric Acid Monohydrate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.